Journal of Medical Economics, Volume 18, Issue 8 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 18, Issue 8 (2015)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Volume 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Original article

Article
Cost–effectiveness of adding ezetimibe to atorvastatin vs switching to rosuvastatin therapy in Portugal
Pedro A. Laires, Flavia Ejzykowicz, Tun-Ying Hsu, Baishali Ambegaonkar & Glenn Davies
Pages: 565-572
Published online: 10 Apr 2015
AbstractforCost–effectiveness of adding ezetimibe to atorvastatin vs switching to rosuvastatin therapy in Portugal | Full Text | References | PDF (203.1 KB)
  • 1249 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access

Original research

Article
Cost-effectiveness of once daily GLP-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway
Pernilla Huetson, James L. Palmer, Andrée Levorsen, Marie Fournier, Maeva Germe & Euan McLeod
Pages: 573-585
Published online: 01 Jun 2015
AbstractforCost-effectiveness of once daily GLP-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway | Full Text | References | PDF (213.6 KB)
  • 1496 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access

Original article

Article
Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers
J. Bradford Rice, Urvi Desai, Ljubica Ristovska, Alice Kate G. Cummings, Howard G. Birnbaum, Michelle Skornicki, David J. Margolis & Nathan B. Parsons
Pages: 586-595
Published online: 22 Apr 2015
AbstractforEconomic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers | Full Text | References | PDF (140 KB)
  • 2663 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access

Editorial

Editorial
Costing bias in economic evaluations
Julie Frappier, Gabriel Tremblay, Mark Charny & L. Martin Cloutier
Pages: 596-599
Published online: 09 Jun 2015
AbstractforCosting bias in economic evaluations | Full Text | References | PDF (60.5 KB)
  • 2224 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access

Original research

Article
Budgetary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for Medicaid in the United States
Carl V. Asche, Emilie Clay, Elizaveta Kharitonova, Vladimir Zah, Jane Ruby & Samuel Aballéa
Pages: 600-611
Published online: 20 May 2015
AbstractforBudgetary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for Medicaid in the United States | Full Text | References | PDF (205.5 KB)
  • 1185 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Article
Inhaled nitric oxide in term/late preterm neonates with hypoxic respiratory failure: estimating the financial impact of earlier use
G. Ganesh Konduri, Joseph Menzin, Molly Frean, Terry Lee, Jim Potenziano & Joel Singer
Pages: 612-618
Published online: 07 May 2015
AbstractforInhaled nitric oxide in term/late preterm neonates with hypoxic respiratory failure: estimating the financial impact of earlier use | Full Text | References | PDF (360.7 KB)
  • 561 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Original article

Article
Cost-minimization analysis of panitumumab compared with cetuximab for first-line treatment of patients with wild-type RAS metastatic colorectal cancer
Christopher N. Graham, Guy Hechmati, Marwan G. Fakih, Hediyyih N. Knox, Gregory A. Maglinte, Jonas Hjelmgren, Beth Barber & Lee S. Schwartzberg
Pages: 619-628
Published online: 20 May 2015
AbstractforCost-minimization analysis of panitumumab compared with cetuximab for first-line treatment of patients with wild-type RAS metastatic colorectal cancer | Full Text | References | PDF (325.1 KB)
  • 1222 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
Estimated medical cost reductions for paliperidone palmitate vs placebo in a randomized, double-blind relapse-prevention trial of patients with schizoaffective disorder
K. Joshi, J. Lin, M. Lingohr-Smith & D. J. Fu
Pages: 629-636
Published online: 22 Apr 2015
AbstractforEstimated medical cost reductions for paliperidone palmitate vs placebo in a randomized, double-blind relapse-prevention trial of patients with schizoaffective disorder | Full Text | References | PDF (343.2 KB)
  • 601 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Original research

Article
Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement
Erik Muser, Chris M. Kozma, Carmela J. Benson, Lian Mao, H. Lynn Starr, Larry Alphs & John Fastenau
Pages: 637-645
Published online: 06 May 2015
AbstractforCost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement | Full Text | References | PDF (130.8 KB) | Supplemental
  • 1218 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
Effectiveness of step therapy policies for specialty pharmaceuticals in immune disorders
Chris M. Kozma, Mike Ingham, Andy Paris & Lorie Ellis
Pages: 646-653
Published online: 24 Apr 2015
AbstractforEffectiveness of step therapy policies for specialty pharmaceuticals in immune disorders | Full Text | References | PDF (231.7 KB)
  • 546 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Explore articles